CXCL2 and Sepsis: Additionally, MIP-2/CXCL2, a potent neutrophil chemoattractant released from murine endothelial cells (and immune cells)[56, 57], was slightly reduced by VT treatment in our experiment and in a murine sepsis model treated with VT[17].